Cutaneous warts and cancer risk
Pro Research Analysisby 
Searched over 200M research papers
Cutaneous Warts, Human Papillomavirus (HPV), and Cancer Risk
HPV Infection, Cutaneous Warts, and Skin Cancer Risk
Cutaneous warts are benign skin lesions caused by infection with human papillomavirus (HPV). While most HPV types that cause warts are considered low-risk, certain subtypes—especially those in the beta-papillomavirus group—have been linked to the development of cutaneous squamous cell carcinoma (cSCC), a type of skin cancer. This association is particularly significant in individuals with compromised immune systems, such as organ transplant recipients and those undergoing chronic immunosuppression, who experience a higher prevalence of both warts and skin cancers 1235+3 MORE.
Immunosuppression, Warts, and Increased Cancer Susceptibility
Immunosuppressed patients, including organ transplant recipients and pediatric oncology patients, are at a much higher risk of developing persistent and multiple warts. These patients also have a dramatically increased risk of skin cancer, especially cSCC. The number of HPV-induced warts in these individuals is strongly associated with the later development of skin cancer, and the time from transplantation to wart development is shorter than the time to first skin cancer diagnosis 1257+2 MORE. In some cases, warts have been observed to undergo neoplastic transformation, directly leading to cancer .
HPV Types and Mechanisms Linking Warts to Cancer
While most warts are caused by low-risk HPV types, persistent infection with certain beta-HPV types is implicated in the development of cSCC. These viruses can be detected in benign, premalignant, and malignant skin lesions, often with multiple HPV types present in a single lesion 136. The E6 protein from some cutaneous HPV types can inhibit apoptosis in response to UV-induced damage, potentially allowing damaged cells to survive and progress to cancer . High viral DNA loads, especially in immunosuppressed individuals, are linked to a significantly increased risk of precancerous lesions and skin cancer .
Clinical Observations and Risk Factors
Clinical studies have shown that renal transplant recipients with multiple seborrhoeic warts are more likely to develop skin cancer . Additionally, certain immunosuppressive drug regimens, particularly those including cyclosporin, are associated with earlier onset of warts and increased cancer risk . Other risk factors for cSCC include UV exposure, age, fair skin, and chemical exposure, but persistent HPV infection is a notable contributor, especially in high-risk populations .
Prevention and Future Directions
Current HPV vaccines target mucosal HPV types associated with anogenital cancers and genital warts, but they do not protect against the beta-HPV types linked to skin cancer. There is ongoing research into vaccines targeting beta-HPV for the prevention of skin tumors, but none have been approved for human use yet . Given the increasing incidence of epithelial skin cancer worldwide, especially among immunocompromised individuals, effective prevention strategies are urgently needed .
Conclusion
Cutaneous warts themselves are benign, but persistent infection with certain HPV types—especially in immunosuppressed individuals—significantly increases the risk of developing skin cancer, particularly cutaneous squamous cell carcinoma. The number and persistence of warts can serve as a marker for increased cancer risk in these populations. Ongoing research into targeted vaccines and improved management strategies is essential to reduce the burden of HPV-associated skin cancers.
Sources and full results
Most relevant research papers on this topic